络泰和黄芪注射液改善冠心病患者血管内皮功能(英文)  

Improvement of vascular endothelial function by luotai and huangqi injection in coronary heart disease patients

作　　者：徐军[1] 黄象娟[2] 齐法莲[1] 曾明顺[1] 杜秀敏[1] 

机构地区：[1]解放军济南军区总医院实验诊断科,山东省济南市250031 [2]山东省卫生学校生化教研室,山东省济南市250002

出　　处：《中国临床康复》2004年第9期1762-1763,共2页Chinese Journal of Clinical Rehabilitation

摘　　要：目的:探讨中药络泰和黄芪注射液与西药结合治疗冠心病的效果和作用机制,分析比较两种药物对冠心病患者血管内皮细胞功能的影响。方法:用RIA和ELISA法检测冠心病患者治疗前后血浆中内皮素-1和血管性假血友病因子(vWF)水平的变化,并与只用西药治疗患者进行比较。 结果:络泰组和黄芪组冠心病患者治疗前血浆中内皮素-1含量为(77.56±15.84)和(76.74±15.30)ng/L,vWF为(97.22±33.84)％和(90.30±17.49)％,水平均明显高于对照组(P<0.01);络泰组和黄芪组在治疗后内皮素-1为(57.90±11.57)和(57.83±8.56)ng/L,vWF含量(59.73±14.8)％和(60.42±17.11)％,两组与治疗前相比明显降低(P<0.01);单用西药组治疗后内皮素-1水平降低的不明显(P>0.05),vWF与治疗前相比差异有显著性意义(P<0.05),与络泰组和黄芪组比差异有显著性意义(P<0.01)。 结论:在常规治疗冠心病西药的基础上,再加以中药络泰和黄芪注射液,可以提高对冠心病的治疗效果,改善血管内皮功能。AIM:To discuss the effects and mechanism of the combined therapy of Traditional Chinese Medicine (TCM) luotai and huangqi( Astragalus root) injection and western medicine in the treatment of coronary heart disease.To analysis and compare the functional index of vascular endothelium of these two TCM in coronary heart disease patients. METHODS:The serous level changes of endothelin-1 (ET-1) and von Willebrand factor (vWF) before and after therapy in coronary heart disease patients were analyzed by RIA and ELISA,and compared with those who only received western medicine therapy. RESULTS:ET-1 content of luotai and huangqi group before therapy was (77.56±15.84) and (76.74±15.30) ng/L respectively;and vMF was (97.22±33.84)% and (90.30±17.49)% respectively,which were all higher than that of the control group(P<0.01).ET-1 content of luotai and huangqi group after therapy was (57.90±11.57) and (57.83±8.56) ng/L respectively;and vMF was (59.73±14.8)% and (60.42±17.11)% respectively,which were both significantly decreased compared with the value before therapy (P<01.01).ET-1 content was no significant decrease after therapy in western medicine therapy group (P>0.05),while the changes of vMF had significant difference (P<0.05).There were significant differences between western medicine therapy group and TCM groups (P<0.01). CONCLUSION:On the basis of routine western medicine therapy in the treatment of coronary heart disease,the therapeutic effectiveness can be increased and the function of vascular endothelium can be improved by com- bining the treatment with TCM luotai and huangqi injection.

关 键 词：络泰注射液 黄芪注射液 冠心病 血管内皮功能 药物治疗 

分 类 号：R259.414[医药卫生—中西医结合]